07/09/2026
Worth a listen.
A peptide gets discovered in the early 1990s. It shows real promise in an animal study. A big biotech firm buys it up, and then, nothing. It never enters phase one, phase two, or phase three of the FDA process. Thirty years pass. In the physician's own words, we have no public knowledge of what happened to it.
None of that has stopped people from talking about it.
That is the story Vikas Patel, an emergency medicine physician, uses to explain the strangest part of the peptide boom. Thousands and thousands of people are now injecting this compound, mostly after hearing about it on podcasts and social media. It runs about $300 a month, sometimes as little as $150, depending on where you get it, and there is essentially zero regulation. As he puts it, you can order some of this from China and it just shows up.
Here is the part that gets him. Statins have been studied in literally millions of patients. This has been studied in fewer than 20. And patients distrust the statin and ask for the peptide. His read is not that patients are foolish. It is that physicians, in his words, have failed to figure out how to communicate and regain trust. The demand is a gap we helped create.
He is also honest about the risk he actually worries about. The compound works partly by increasing blood flow, and increased blood flow, he notes, could also feed cancer cells, so the open long-term question is whether you could be speeding the growth of something like a cancer. He balances that immediately: used short-term, with a clear goal, there is probably not a ton of harm. The real problem is that there is no long-term data on any of it.
And he is fair to the patients. Of the twenty or so very popular peptides, he is sure at least three, four or five of them are probably good. And patients, he says, are not completely wrong. They are not wrong to look for something they are not getting from traditional medicine.
His whole approach comes down to one thing. He would rather patients ask him than go online, eyes wide open, making an informed decision.
On what he will and will not do, he put it this way:
"I'm not prescribing things that I wouldn't take myself. But I'm willing to have the conversation."
Listen to the full conversation on The Podcast by KevinMD. Link in the comments.
